NCT05780645 - A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions

Healthy Participants

Interventions

DRUG

ALXN2050 MR Prototype Tablet

Participants will receive various doses of the MR Prototype Tablet orally.

DRUG

ALXN2050 Immediate Release (IR) Tablet

Participants will receive a single dose IR (ALXN2050 Film Coated Tablet) tablet orally.

DRUG

ALXN2050 MR Prototype Mini-Tablet

Participants will receive various doses of the MR Prototype Mini-Tablet orally.

Trial Locations (1)

Research Site, Ruddington